Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 44
Filter
2.
Parassitologia ; 52(3-4): 405-10, 2010 Dec.
Article in English | MEDLINE | ID: mdl-22320016

ABSTRACT

Human herpesvirus-8 non-sexual transmission occurs primarily from mother-to-child. The viral load in saliva is higher than in other human fluids. Moreover, there is evidence that bloodsucking arthropod bites induce an inflammatory/immune response that facilitates viral replication. We aim to explore possible risk factors in mother-to-child HHV-8 transmission associated with traditional methods which involve the use of saliva to relieve the irritation and skin reaction caused by arthropod bites. We administered questionnaires to 2244 children from several African countries and Italy. Descriptive statistics and logistic regression were used in the analysis of the answers to evaluate the relationships between the use of traditional methods and other risk factors. The use of traditional methods is high in Cameroon (63.0%) and Uganda (39.9%), intermediate in Senegal (26.7%) and Italy (21.7%), low in Madagascar (6.7%). Statistical analyses show significant direct relationships between the use of traditional methods, skin reactions to the bite and their duration in Cameroon, Uganda and Senegal. The use of saliva and herbs applied by the mothers on the child's skin, is a common habit in Africa. If this practice plays a role in the HHV-8 transmission, then, it could provide the basis for interventions capable of reducing the health impact of the infection in children in tropical areas.


Subject(s)
Herpesviridae Infections/transmission , Herpesvirus 8, Human/physiology , Insect Bites and Stings/therapy , Medicine, African Traditional/adverse effects , Mothers , Saliva/virology , Adult , Africa, Western/epidemiology , Animals , Child , Child, Preschool , Comorbidity , Female , Herpesviridae Infections/epidemiology , Herpesviridae Infections/prevention & control , Herpesvirus 8, Human/isolation & purification , Humans , Infant , Insect Bites and Stings/epidemiology , Italy/epidemiology , Madagascar/epidemiology , Male , Phytotherapy/methods , Risk Factors , Seroepidemiologic Studies , Surveys and Questionnaires , Virus Replication
7.
Transplant Proc ; 36(3): 680-2, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15110629

ABSTRACT

In the general population, the likelihood of an individual receiving a transfusion has been calculated to be about 0.89% per year, increasing dramatically with age. Massive intraoperative hemorrhage from trauma, cardiopulmonary bypass, and orthotopic liver transplantation need substantial replacement therapy. In renal transplantation, blood transfusion is a debated induction tool for specific allograft tolerance, since it causes a nonspecific down-regulation of immune function. In transplantations, in humoral immune deficiencies, in hematological disorders, and in HIV infection, the intravenous immunoglobulin prophylaxis may alter the monocyte/macrophage system host immunity and immune surveillance against infection, tissue or cell damage, and malignancy. Some persons, like Jehovah's Witnesses, object to transfusion of blood products, posing ethical and practical issues concerning treatment of blood disorders, transplantation, and trauma. In this review we examined the actual risk of contracting an infectious disease from an allogeneic blood transfusion to contribute to an uneasy decision-making process. We have found that the procedure is presently considerably safe.


Subject(s)
Infections/epidemiology , Infections/transmission , Transfusion Reaction , Bacterial Infections/epidemiology , Bacterial Infections/transmission , Humans , Protozoan Infections/epidemiology , Protozoan Infections/transmission , Risk Factors , Virus Diseases/epidemiology , Virus Diseases/transmission
9.
Acta Virol ; 44(3): 137-43, 2000.
Article in English | MEDLINE | ID: mdl-11155355

ABSTRACT

Cerebrospinal fluid (CSF) samples from 49 acquired immunodefficiency disease syndrome (AIDS) patients with a central nervous system (CNS) disease were examined by polymerase chain reaction (PCR) to evaluate the association between the positivity for cytomegalovirus (CMV) and Epstein-Barr virus (EBV), and clinical diagnosis of a CNS disease. Frequency and clinical relevance of detection of DNA of human herpesviruses 6 (HHV-6), 7 (HHV-7) and 8 (HHV-8) were also determined. DNA of one or more of the following viruses was found in 26 of 49 patients (53%): CMV in 16 (33%), EBV in 13 (27%), human herpesvirus 6 (HHV-6) in 2 (4%), human herpesvirus 7 (HHV-7) in 1 (2%), and human herpesvirus 8 (HHV-8) in 1 (2%). The CMV detection was significantly associated with encephalitis and peripheral neuropathy (7/16 vs. 2/33, p = 0.003), while EBV with primary CNS lymphoma (P-CNSL) (8/13 vs. 0/36, p < 0.0001). HHV-6 DNA was found in CSF of two patients with neuroradiological features suggestive of cerebral lesions. HHV-8 or HHV-7 DNA was detected in the CSF of patients with unexplained neurological symptoms. This study confirms that the PCR analysis of CSF is a valid tool for the diagnosis of neurological diseases associated with CMV and EBV. On the other hand, HHV-6, HHV-7 and HHV-8, instead, were rarely detected in CSF of AIDS patients and have certainly no correlation with the CNS disease found.


Subject(s)
AIDS-Related Opportunistic Infections/virology , Acquired Immunodeficiency Syndrome/complications , Central Nervous System Diseases/complications , Cytomegalovirus Infections/complications , Cytomegalovirus/isolation & purification , DNA, Viral/cerebrospinal fluid , AIDS-Related Opportunistic Infections/cerebrospinal fluid , Central Nervous System Diseases/cerebrospinal fluid , Central Nervous System Diseases/virology , Cytomegalovirus/genetics , Cytomegalovirus Infections/cerebrospinal fluid , Cytomegalovirus Infections/virology , Encephalitis, Viral/complications , Encephalitis, Viral/virology , Epstein-Barr Virus Infections/cerebrospinal fluid , Epstein-Barr Virus Infections/complications , Epstein-Barr Virus Infections/virology , Herpesvirus 4, Human/genetics , Herpesvirus 4, Human/isolation & purification , Herpesvirus 6, Human/genetics , Herpesvirus 6, Human/isolation & purification , Herpesvirus 7, Human/genetics , Herpesvirus 7, Human/isolation & purification , Herpesvirus 8, Human/genetics , Herpesvirus 8, Human/isolation & purification , Humans , Lymphoma, AIDS-Related/complications , Lymphoma, AIDS-Related/virology , Peripheral Nervous System Diseases/complications , Peripheral Nervous System Diseases/virology , Polymerase Chain Reaction
10.
J Hum Virol ; 2(1): 38-44, 1999.
Article in English | MEDLINE | ID: mdl-10200598

ABSTRACT

OBJECTIVES: To study the cellular localization of human herpesvirus 8 (HHV-8) in rare cases of HHV-8 infection from Italy that are associated neither with human immunodeficiency virus (HIV) infection nor Kaposi's sarcoma (KS). METHODS: The presence and distribution of HHV-8-infected cells was investigated by direct in situ polymerase chain reaction (PCR) in the lymph node tissues from 2 patients with reactive lymphadenopathies with florid follicular hyperplasia and increased vascularity and in the lung tissue from 1 patient with chronic interstitial pneumonitis. RESULTS: HHV-8 was localized in lymphoid and monocyte-macrophage cells scattered in the interfollicular regions of both lymph nodes but not in endothelial cells. In the lung tissue, HHV-8 was found in the inflammatory cells infiltrating the interalveolar interstitium, in endothelial cells of the pulmonary vasculature, and in rare pneumocytes. CONCLUSIONS: HHV-8 can infect nonneoplastic lymph nodes of immunocompetent subjects, and the distribution of infected cells outside of the germinal centers resembles that of Epstein-Barr virus (EBV)-infected cells in the lymph nodes in the course of infectious mononucleosis. Endothelial cells and pneumocytes may be a target of HHV-8 infection out of the KS setting, at least in the presence of a chronic inflammatory process.


Subject(s)
Herpesviridae Infections/virology , Herpesvirus 8, Human/isolation & purification , Lung Diseases, Interstitial/virology , Lymphatic Diseases/virology , Polymerase Chain Reaction/methods , Herpesviridae Infections/diagnostic imaging , Herpesviridae Infections/pathology , Herpesvirus 8, Human/genetics , Humans , Lung Diseases, Interstitial/pathology , Lymphatic Diseases/diagnostic imaging , Lymphatic Diseases/pathology , Tomography, X-Ray Computed/methods
11.
Orv Hetil ; 140(46): 2577-80, 1999 Nov 14.
Article in Hungarian | MEDLINE | ID: mdl-10628199

ABSTRACT

Simultaneous HHV-6A infection can activate HIV-1 latency and promote AIDS progression, but in this process the effects of HHV-6A induced soluble mediators on HIV-1 have not been studied yet. Recently, supernatants of HSB-2 cultures infected with HHV-6A and/or treated with endotoxin have been filtered virus free at time intervals until the cytopathic effect developed. Biological activity of some cytokines which might participate in HIV-1 activation was quantitated. Filtered supernatants were mixed into CEM-ss cultures, which had been HIV-1 infected at 1:1 cell:virus ratio, subsequently HIV-1 replication was quantitated and compared to controls. Supernatants filtered during the first 96 hours of HHV-6A replication without visible cytopathic effect augmented HIV-1 syncytium formation by tenfold, reverse transcriptase activity by threefold, p24 antigen production by 6-fold. Filtered supernatants obtained at onset of HHV-6A cytopathic effect did not modify HIV-1 replication. HSB-2 cultures produced no IL-2, and IFN-gamma induced by endotoxin diminished HIV-1 replication. HHV-6A delayed IFN-gamma release. An increase in the tumour necrosis factor activity upon the effect of HHV-6A and endotoxin was not parallel to HIV-1 activation. The putative mediator, different from those above which characterisation is in progress, might transmit similar transactivating effects between immune cells of lymph nodes and circulation.


Subject(s)
Endotoxins/pharmacology , HIV-1 , Herpesvirus 6, Human , Humans , In Vitro Techniques , Solubility
12.
J Acquir Immune Defic Syndr Hum Retrovirol ; 14(5): 408-14, 1997 Apr 15.
Article in English | MEDLINE | ID: mdl-9170414

ABSTRACT

To determine the influence of HIV-1 replication on immunologic decline and clinical outcome, we quantified the HIV-1 plasma viral load in 20 patients at different times over a mean period of 10.8 months. Quantitation was performed by branched DNA signal amplification (bDNA) and p24 antigenemia. Immunologic status was assessed through beta 2-microglobulin and CD4+ cell count determinations. CD4+ cell decline was expressed as a slope of the regression line constructed by the logarithms of CD4+ cell count observations. Mean values of plasma viral load were correlated with CD4+ cell decline and mean beta 2-microglobulin levels. Significant correlation was observed between plasma viral load quantified by the bDNA technique and CD4+ cell decline. No significant correlation was observed between plasma viral load quantified by p24 antigenemia and CD4+ cell decline. A significant correlation was observed between plasma viral load and beta 2-microglobulin levels. Immunologic decline was better predicted from HIV-1 RNA levels than from the CD4+ cell count. Significantly higher plasma viral load was observed in patients who had clinical progression of HIV-1 infection. Thus, HIV-1 plasma viral load quantified by a highly reliable technique such as bDNA showed that the immunologic decline is closely related to HIV-1 RNA replication.


Subject(s)
HIV Infections/immunology , HIV-1/genetics , RNA, Viral/blood , Viremia/immunology , Virus Replication/immunology , Anti-HIV Agents/therapeutic use , CD4 Lymphocyte Count , DNA, Viral/analysis , Didanosine/therapeutic use , Disease Progression , Drug Therapy, Combination , HIV Core Protein p24/blood , HIV Infections/drug therapy , HIV-1/physiology , Humans , Longitudinal Studies , Stavudine/therapeutic use , Viral Load , Viremia/drug therapy , Zalcitabine/therapeutic use , Zidovudine/therapeutic use , beta 2-Microglobulin/analysis
13.
J Med Virol ; 51(4): 259-64, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9093938

ABSTRACT

After primary infection, human herpesvirus-6 (HHV-6) persists in latent form and can be reactivated in immunocompromised subjects. A longitudinal study of HHV-6 infection was carried out in two HIV-1 seropositive patients to provide in vivo evidence of HHV-6 reactivation. Concomitant with a significant rise of anti-HHV-6 IgG detected by IFA, a transient increase of HHV-6 viral load was shown in PBLs by PCR. During HHV-6 reactivation it was also identified either cell-free HHV-6 by PCR in plasma or IgM antibody titers. HHV-6 reactivation was followed by a temporary decrease in CD4+ count and by a progressive dramatic loss of CD4+ during the following 18 months. HHV-6 strain characterization by PCR demonstrated that first patient (MM) initially showed the B variant, followed by reactivation and persistence of the A variant, while in the second (SG) only the A variant was detected. The evidence of HHV-6 reactivation suggests its involvement in immunologic damage underlying the disease.


Subject(s)
AIDS-Related Opportunistic Infections/virology , HIV-1 , Herpesviridae Infections/virology , Herpesvirus 6, Human/growth & development , Virus Activation , AIDS-Related Opportunistic Infections/blood , AIDS-Related Opportunistic Infections/immunology , Antibodies, Viral/blood , CD4 Lymphocyte Count , DNA, Viral/blood , Female , Herpesviridae Infections/blood , Herpesviridae Infections/complications , Herpesviridae Infections/immunology , Herpesvirus 6, Human/genetics , Herpesvirus 6, Human/immunology , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Longitudinal Studies , Male , Polymerase Chain Reaction
14.
Infection ; 24(4): 292-6, 1996.
Article in English | MEDLINE | ID: mdl-8875280

ABSTRACT

Using bDNA, the plasma viral load trend of HCV-infected patients undergoing IFN therapy was analyzed. Nine patients were enrolled, each assigned to one of three groups, based on IFN response as determined by ALT and AST level trend. HCV was genotyped using DEIA. Each patient's clinical stage was determined by liver biopsy analysis. In nonresponding patients elevated viral loads and biochemical parameters were observed. These values were not influenced by IFN treatment. In relapsed patients the cessation of IFN treatment increased viral load; this was associated with a rise in ALT and AST values. In responders ALT and AST levels remained normal; viral load was low. Patients with elevated HCV viral load showed a worsening in their liver histology during the follow-up period. These results confirm that plasma viral load is a good marker of biochemical change and disease progression.


Subject(s)
DNA, Viral/analysis , Hepacivirus/genetics , Hepatitis C/virology , Interferon-alpha/therapeutic use , RNA, Viral/analysis , Adult , Alanine Transaminase/metabolism , Aspartate Aminotransferases/metabolism , Female , Follow-Up Studies , Gene Amplification , Hepatitis C/blood , Hepatitis C/drug therapy , Humans , Liver/pathology , Longitudinal Studies , Male , Middle Aged , Viremia
15.
Blood ; 87(9): 3903-9, 1996 May 01.
Article in English | MEDLINE | ID: mdl-8611719

ABSTRACT

Human herpesvirus-8 (HHV-8) DNA sequences have been reported to be strictly associated not only with various forms of Kaposi's sarcoma but also with an unusual subgroup of acquired immunodeficiency syndrome (AIDS)-related B-cell lymphomas. A possible relation of this putative virus also with multicentric Castleman's disease (MCD) has been recently suggested. We used polymerase chain reaction to look for the presence of HHV-8 sequences in a well characterized series of benign, atypical, and malignant lymphoid tissues from 45 Hodgkin's disease and 43 non-Hodgkin's lymphoma (NHL) cases, as well as from 5 MCD, 15 angioimmunoblastic lymphadenopathy (AILD), and 23 benign lymphadenopathy cases. Among the 38 AIDS-related lymphoid lesions, only 1 NHL and 1 persistent generalized lymphadenopathy (PGL) case were positive. Furthermore, among the 92 non-AIDS-related lymphoproliferative disorders, HHV-8 sequences were detected in 3 classic AILD cases and in 4 reactive lymphadenopathies. Six of 9 HHV-8 positive lymphoid lesions (1 NHL, 1 PGL, 1 AILD, and 3 reactive lymphadenopathy cases) were also positive for Epstein-Barr viral sequences. The four human immunodeficiency virus (HIV) negative lymphadenopathies positive for HHV-8 sequences showed an almost identical histology, characterized by a predominantly follicular lesion, with giant germinal center hyperplasia, and increased vascularity, resembling HIV-related lymphadenopathy and MCD. Our results, while providing the first evidence of the presence of HHV-8 sequences in AILD cases, suggest a possible association of these herpes viral sequences with a distinct histologic type of non-neoplastic lymphadenopathy, not associated with other common herpes infections.


Subject(s)
Herpesviridae/isolation & purification , Hodgkin Disease/virology , Immunoblastic Lymphadenopathy/virology , Lymphoma, AIDS-Related/virology , Lymphoma, Non-Hodgkin/virology , Base Sequence , DNA, Viral/analysis , Hodgkin Disease/pathology , Humans , Hyperplasia , Immunoblastic Lymphadenopathy/pathology , Lymph Nodes/blood supply , Lymph Nodes/pathology , Lymphoma, AIDS-Related/pathology , Lymphoma, Non-Hodgkin/pathology , Molecular Sequence Data , Neovascularization, Pathologic , Sequence Analysis
16.
Int J Cancer ; 66(4): 427-31, 1996 May 16.
Article in English | MEDLINE | ID: mdl-8635855

ABSTRACT

The frequency and distribution of herpesvirus-like DNA sequences (KSHV) were investigated by PCR in the pathologic skin lesions of a series of 22 HIV-negative elderly patients with classic Kaposi's sarcoma (KS) from Italy, one of the few regions of the world where classic KS is prevalent. Viral sequences were clearly identifiable in 15 cases, in particular in 2 of 5 patch, in 3 of 6 plaque and in 10 of 11 nodular lesions. Our findings confirm the association of these herpesvirus-like DNA sequences with KS in unrelated populations, providing evidence of the putative KS-associated agent in all different histologic lesions of the disease, mainly in the nodular stage. The search for other herpesviruses by PCR showed that Epstein-Barr virus (EBV) sequences were present in 7 of 22 pathologic skin lesions. In 4 cases, both EBV and KSHV were present. On the contrary, all 22 classic KS specimens were negative for human herpesvirus-6 sequences. Two of 3 patch and the 1 nodular lesions from AIDS-related KS patients examined were positive for KSHV but negative for both EBV and HHV-6 sequences. Furthermore, we evaluated the prevalence of KSHV sequences in the normal population of the same geographical area. Thirteen peripheral blood mononuclear cell samples, 9 salivary gland tissues and 6 saliva samples from healthy subjects were invariably found negative for KSHV, using the same PCR technique. Of interest, 2 of 11 hyperplastic tonsils harboured these herpesvirus-like sequences, suggesting that, like other herpesviruses, the KS- associated agent may be harboured in a proportion of normal individuals and tonsils may represent at least one of the possible reservoirs of this putative lymphotropic gamma-herpesvirus in vivo.


Subject(s)
DNA, Viral/analysis , Herpesviridae Infections/epidemiology , Herpesviridae/genetics , Sarcoma, Kaposi/microbiology , Acquired Immunodeficiency Syndrome/microbiology , Aged , Humans , Italy , Lymphoid Tissue/microbiology , Middle Aged , Retrospective Studies
17.
J Med Virol ; 47(1): 105-11, 1995 Sep.
Article in English | MEDLINE | ID: mdl-8551252

ABSTRACT

In an attempt to study the frequency and distribution of human herpesvirus-6 (HHV-6) infection both in normal and neoplastic brain tissues in vivo, polymerase chain reaction was used to look for HHV-6 genomes: 1) in samples, obtained at necropsy, from different regions of the brain of immunocompetent adult subjects and of patients who died of AIDS; 2) in the surgical biopsies of a well-characterized series of primary brain tumors of neuroglial origin. HHV-6-specific sequences were identified in six of nine brain samples from immunocompetent subjects, and in four of seven brain samples from AIDS patients. Viral sequences were identified in the specimens derived either from the grey (frontal cortex and basal ganglia) or from the periventricular white matter. HHV-6 DNA was found only in 6 of the 37 primary brain tumor biopsies examined. This study provides for the first time molecular evidence of a wide distribution of HHV-6 infection in the brain tissues of a high proportion of subjects, both in normal and in impaired immunity. In this large series of tumor biopsies the presence of HHV-6 genomic sequences is a rare phenomenon, arguing against a major role of this herpesvirus in the pathogenesis of primary brain tumors of neuroglial origin in immunocompetent subjects.


Subject(s)
Brain Neoplasms/virology , Brain/virology , DNA, Viral/analysis , Herpesvirus 6, Human/isolation & purification , Acquired Immunodeficiency Syndrome/pathology , Acquired Immunodeficiency Syndrome/virology , Adult , Brain Neoplasms/pathology , Genome, Viral , Herpesvirus 4, Human/genetics , Herpesvirus 4, Human/isolation & purification , Herpesvirus 6, Human/genetics , Humans , Immunocompetence
19.
New Microbiol ; 18(3): 299-301, 1995 Jul.
Article in English | MEDLINE | ID: mdl-7553365

ABSTRACT

To detect HIV-1 plasma viral load in seropositive patients, we applied a new molecular quantitation technique: branched DNA signal amplification (bDNA). We performed bDNA with 99 sera from HIV-1 seropositive patients undergoing antiretroviral therapy. We compared the results obtained with p24 antigenemia and CD4+ cell count. The bDNA proved quite sensitive and available for routine use in laboratories.


Subject(s)
Blood/virology , HIV Seropositivity/blood , HIV-1/isolation & purification , Nucleic Acid Hybridization , RNA, Viral/isolation & purification , Antibodies, Monoclonal/immunology , CD4 Lymphocyte Count , DNA Probes/genetics , Enzyme-Linked Immunosorbent Assay , Female , HIV Core Protein p24/analysis , HIV-1/immunology , Humans , Luminescent Measurements , Male
20.
J Med Virol ; 46(3): 178-88, 1995 Jul.
Article in English | MEDLINE | ID: mdl-7561787

ABSTRACT

Out of 64 cases of non-Hodgkin's lymphomas (NHL), 55 cases of Hodgkin's disease (HD) and 31 cases of multiple sclerosis (MS), 2 NHL, 7 HD and 1 MS cases were found positive by polymerase chain reaction (PCR) for the presence of HHV-6 sequences in pathologic lymph nodes of the lymphomas and in peripheral blood mononuclear cells (PBMCs) of MS. A further analysis of the PBMCs of the PCR positive cases by standard Southern blot technique revealed only 2 NHL, 3 HD and 1 MS cases as positive, indicating that these six patients have an unusually high viral copy number in the PBMCs. Restriction analysis, carried out using probes representative of different regions of the virus, showed that three cases retain only a deleted portion of the viral genome. In the remaining three cases a complete viral genome was present, containing the right end sequences in which the rep-like gene, possibly crucial to the viral and cellular life cycle, is located. The analysis by pulsed field gel electrophoresis (PFGE) of the total DNA of the PBMCs obtained directly, without culture from PBMCs of these last three cases (1 NHL, 1 HD, and 1 MS), using the same probes, showed the absence of free viral molecules and the association of viral sequences with high molecular weight DNA. These results are consistent with in vivo integration of the entire virus in the cellular genome. A further study of the same patients with chromosome fluorescence in situ hybridization (FISH) showed in all the three cases the presence of a specific hybridization site, located at the telomeric extremity of the short arm of chromosome 17 (17p13), suggesting that this location is at least a preferred site of an infrequent, but possibly biologically important, integration phenomenon.


Subject(s)
Chromosomes, Human, Pair 17 , Herpesviridae Infections/virology , Herpesvirus 6, Human/genetics , Leukocytes, Mononuclear/virology , Virus Integration , Adult , Antibodies, Viral/blood , Blotting, Southern , Cell Line , DNA, Viral/analysis , Electrophoresis, Gel, Pulsed-Field , Female , Herpesviridae Infections/genetics , Herpesviridae Infections/immunology , Herpesvirus 6, Human/immunology , Hodgkin Disease/virology , Humans , In Situ Hybridization, Fluorescence , Lymph Nodes/virology , Lymphoma, Non-Hodgkin/virology , Male , Middle Aged , Multiple Sclerosis/virology , Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...